Medgenics, Inc. announced the appointment of Eric Phillips, MPH, ScD as Vice President of Regulatory Affairs. In this role, Dr. Phillips will be a key member of the Medgenics leadership team setting the strategy and tactics for all regulatory activities. Dr. Phillips has held positions of increasing responsibility in Regulatory Affairs, most recently at Bristol-Myers Squibb, where he led the successful submission for the approval of Opdivo in the treatment of squamous non-small cell lung cancer, and the recent submission of the supplemental Biologics License Appilcation for the use of Opdivo in the treatment of Hodgkin lymphoma.